To evaluate PTPRZ1 antigen levels required for TCR-T efficacy, we next assessed the expression levels of PTPRZ1 in our panel of generated primary spheroid glioblastoma cell lines. The gene discussed is PTPRZ1; the disease is glioblastoma.